Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults
- PMID: 16870528
- DOI: 10.1016/S1473-3099(06)70550-3
Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults
Abstract
Despite dramatic declines in HIV-associated morbidity and mortality as a result of highly active antiretroviral therapy, management of heavily treatment-experienced patients remains complex and challenging. Treatment response rates with subsequent antiretroviral regimens are lower than with initial antiretroviral therapy. Additionally, increased mortality has been associated with multidrug-resistant HIV. We review data relevant to management of such patients and offer a systematic approach to constructing a salvage antiretroviral regimen.
Similar articles
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Treatment of antiretroviral-drug-resistant HIV-1 infection.Lancet. 2003 Dec 13;362(9400):2002-11. doi: 10.1016/S0140-6736(03)15022-2. Lancet. 2003. PMID: 14683662 Review.
-
Salvage therapy for patients failing their current antiretroviral regimen.AIDS Clin Rev. 2000-2001:139-91. AIDS Clin Rev. 2000. PMID: 10999220 Review. No abstract available.
-
Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.Prescrire Int. 2004 Aug;13(72):144-50. Prescrire Int. 2004. PMID: 15532140
-
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.AIDS. 2006 Jul 13;20(11):1558-60. doi: 10.1097/01.aids.0000237375.23692.f4. AIDS. 2006. PMID: 16847414
Cited by
-
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study.HIV Med. 2025 Jan;26(1):17-25. doi: 10.1111/hiv.13700. Epub 2024 Aug 25. HIV Med. 2025. PMID: 39183479 Free PMC article.
-
Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection.J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):149-55. doi: 10.1097/QAI.0b013e31816d9c3b. J Acquir Immune Defic Syndr. 2008. PMID: 18360289 Free PMC article.
-
Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process.Mol Biol Int. 2012;2012:604261. doi: 10.1155/2012/604261. Epub 2012 Jul 25. Mol Biol Int. 2012. PMID: 22888428 Free PMC article.
-
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.PLoS One. 2009 Dec 14;4(12):e8275. doi: 10.1371/journal.pone.0008275. PLoS One. 2009. PMID: 20011544 Free PMC article.
-
Tipranavir: a review of its use in the management of HIV infection.Drugs. 2008;68(10):1435-63. doi: 10.2165/00003495-200868100-00006. Drugs. 2008. PMID: 18578560 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical